MicrobiologybioRxiv
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA SARS 2 S in preclinical vaccination
A. Tscherne, J. H. Schwarz, C. Rohde…·A. Volz
This paper describes the preclinical evaluation of MVA-SARS-2-S, a vector vaccine against SARS-CoV-2, showing it induces immune responses and protects mice from infection.
DOI 10.1073/pnas.2026207118